Testing the Addition of An Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Pancreatic Neuroendocrine Tumors
Clinical trial NCT04750954 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04750954
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-22
- Primary completion
- 2026-12-30
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.